What if you could detect changes in your eye and brain health from home?
JuneBrain is extending the ophthalmology clinic to patients' homes.
A Mission of Empowerment
We are providing a telehealth eye-scanning solution that allows providers to identify new disease activity outside of the clinic for the more than 500 million individuals worldwide suffering from retinal and neurological disease.
Our Solution
The Eye
Your retina is a thin piece of tissue at the back of your eye. In some diseases, the retina changes.
JuneBrain's Telehealth Eye-Scanning System
Either in the clinic or in the comfort of your home, we can detect retinal changes without touching the eye and without hurting you.
Sharing Data with Your Providers
We analyze these images and securely send them to your provider. Your physician now has more data to help you.
Patient-Centered Care
On top of the eye data sent to your provider, you can choose to use JuneBrain's mobile platform to:
-
Share symptoms
-
Connect with your caregivers and providers
-
Read expert-verified educational material
-
Prepare for your next visit
How it Works
Our telehealth system is designed for easy use in the clinic or at home and automated communication of your health with your provider.
Be sure to unmute to hear the audio
Number of Patients Impacted by Retinal and Neurological Disease
in the US
14,000,000
Age-Related Macular
Degeneration (AMD)
7,700,000
Diabetic Retinopathy
3,000,000
Glaucoma
1,000,000
Multiple Sclerosis (MS)
5,500,000
Alzheimer's Disease
930,000
Parkinson's Disease
Latest Blogs
Learn more about our solution, the industry and some interesting insights via our blog posts below:
NEWS FEED
July 2022: JuneBrain is awarded a $100k Maryland Industrial Partnerships (MIPS) grant for its clinical studies in collaboration with the University of Maryland Baltimore.
About Us
JuneBrain Inc. was founded in Maryland with the vision of empowering the ophthalmology and neurology communities through remote monitoring of eye and brain health.
Contact Us
Email: info@junebrain.com
Follow Us
